Montine T J, Vandersteenhoven J J, Aguzzi A, Boyko O B, Dodge R K, Kerns B J, Burger P C
Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Neurosurgery. 1994 Apr;34(4):674-8; discussion 678-9. doi: 10.1227/00006123-199404000-00016.
Histological grading of fibrillary astrocytic neoplasms has proved to be a valuable prognostic tool, but potentially could benefit from more objective data, such as estimates of proliferative rate. The authors have investigated the prognostic utility of quantitative Ki-67 immunoreactivity in a prospective survival analysis of 36 adult patients with astrocytoma, anaplastic astrocytoma, or glioblastoma multiforme diagnosed between 1987 and 1992. A digital image analyzer was used to assay proliferation indices (PIs) in surgical biopsy specimens obtained at first diagnosis (32 of 36) or at a second biopsy of histologically unchanged high-grade disease (4 of 36). A Ki-67 PI of > or = 7.5% was associated with higher histological grade and poorer survival, and the Ki-67 PI was more significantly related to survival (P < 0.001) than histological grade as determined by a modified Ringertz grading system (P = 0.002). Survival analysis within histological grades suggested that astrocytoma patients with PI > or = 3% may be at increased risk for shorter survival than those with PI < 3%.
纤维性星形细胞瘤的组织学分级已被证明是一种有价值的预后工具,但可能会从更客观的数据中受益,比如增殖率的估计值。作者在一项对1987年至1992年间诊断的36例成年星形细胞瘤、间变性星形细胞瘤或多形性胶质母细胞瘤患者的前瞻性生存分析中,研究了定量Ki-67免疫反应性的预后效用。使用数字图像分析仪检测首次诊断时(36例中的32例)或组织学未改变的高级别疾病二次活检时(36例中的4例)获取的手术活检标本中的增殖指数(PI)。Ki-67 PI≥7.5%与更高的组织学分级和更差的生存率相关,并且与经改良的林格茨分级系统确定的组织学分级(P = 0.002)相比,Ki-67 PI与生存率的相关性更显著(P < 0.001)。组织学分级内的生存分析表明,PI≥3%的星形细胞瘤患者与PI<3%的患者相比,生存时间缩短的风险可能增加。